Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The potential of plant-derived vesicles in treating periodontitis and associated systemic diseases: current advances and future directions

Liu Z., Guo Y., Deng Y., Shao J., Huang X., Cao Z.

Narrative Review on Chronic Inflammation, published in J Nanobiotechnology (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Nanobiotechnology (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40826362
PMCID
PMC12359970
DOI
10.1186/s12951-025-03651-0
Citations
1

Abstract (original English)

Background Periodontitis, a chronic multifactorial inflammatory disease, represents a significant public health burden among global chronic non-communicable diseases. In addition to affecting oral health, periodontitis is closely associated with a variety of systemic diseases. Current treatments, including surgical and nonsurgical therapies, lack clear superiority, underscoring the need for innovative therapeutic strategies. Plant-derived vesicles (PDVs), as natural products, have the advantages of being highly biocompatible, rich in biologically active components, and easy to cross biological barriers. Recent studies have shown that PDVs may treat periodontitis by maintaining oral microecological balance, remodeling the periodontal immune microenvironment, regulating inflammatory responses and oxidative stress, and promoting periodontal tissue regeneration. This review synthesizes the nomenclature based on MISEV 2023 and the latest research advances from biogenesis to removal, pre-processing, isolation, and characterization methods. It systematically evaluates potential applications of PDVs in periodontitis and associated systemic diseases, and presents the challenges facing current research. Conclusion PDVs hold promise as a novel, multitargeted approach for periodontitis and its systemic systemic diseases. However, overcoming limitations in production consistency, mechanisti

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansPlantsPeriodontitisBiological ProductsExtracellular Vesicles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research